News

BioCryst targets $1B ORLADEYO peak and $700M cash by 2027 as leadership shifts and pipeline advances

Q2 2025 Management View CEO Jon P. Stonehouse stated that "Q2 was another outstanding quarter of performance for BioCryst.

The worst of the tariffs is still yet to come, says JPMorgan's Joyce Chang

Joyce Chang, JPMorgan chair of global research, joins 'Money Movers' to discuss markets the impact of tariffs on the market ...